Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • najoshi
    Member
    • Feb 2010
    • 20

    snpEff database provenance and custom builds

    I am currently using snpEff to do effect prediction and I had a few questions. First, does someone have detailed information about the provenance of the data that was used to create the databases? I.e., where did he get the data to create all of those databases? I can't seem to find that on the website, and in the paper he mentions Ensembl, UCSC, etc. but no details.

    I am also trying to create a new database for snpEff using another annotation, and I am running into problems. The annotation is a xenoRefGene annotation from UCSC, which means that it is genes from other organisms mapped to our genome of interest. However, this means that some of the genes/gene families might be mapped to more than one location. This seems to be causing problems in building the database, because I get many errors that look like this when I run snpEfff build:

    Ignoring exon outside chromosome range (chromo length: 80642250). Exon: 6:82316946-82317137 'exon_chr7_82316947_82317138' rank:0, sequence:

    It looks like the exon it is seeing is from the same gene, but a different chromosome. I looked at the gene IDs and they are the same for those two regions. Does anybody know of any scripts, or are there options in snpEff to deal with this sort of issue? Any help would be highly appreciated. Thanks!

    - Nik.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
41 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...